Kingsview Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,000
Closed -$2K 1008
2021
Q3
$2K Buy
+1,000
New +$171K ﹤0.01% 869
2018
Q3
Sell
-1,000
Closed -$1K 429
2018
Q2
$1K Buy
+1,000
New +$125K ﹤0.01% 368
2017
Q4
Sell
-300
Closed -$1K 415
2017
Q3
$1K Sell
300
-2,800
-90% -$371K ﹤0.01% 346
2017
Q2
$2K Buy
3,100
+100
+3% +$12.8K ﹤0.01% 317
2017
Q1
$2K Buy
+3,000
New +$358K ﹤0.01% 275

Other funds holding JNJ

Kingsview Wealth Management's JNJ Position: Q1 2026 in Review

Kingsview Wealth Management reduced its Johnson & Johnson (JNJ) stake by 7.4% in Q1 2026, selling an estimated $1.84M and leaving 98,946 shares worth $24.2M. The position accounts for 0.33% of the portfolio, ranked #53.

Kingsview Wealth Management first reported a position in JNJ in Q1 2017 and has held it in 37 quarters since. The position peaked at $24.7M in Q3 2024. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kingsview Wealth Management held 98,946 shares of Johnson & Johnson worth $24.2M as of Q1 2026.
  • Kingsview Wealth Management sold 7,901 Johnson & Johnson shares in Q1 2026, an estimated $1.84M.
  • Johnson & Johnson made up 0.33% of Kingsview Wealth Management's portfolio in Q1 2026, its #53 holding.
  • Kingsview Wealth Management first reported a position in Johnson & Johnson in Q1 2017 and has held it in 37 quarters since.
  • Kingsview Wealth Management's Johnson & Johnson position peaked at $24.7M in Q3 2024.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.